Sort
39,280 grants matching “leukemia”
Erythroid Development in the Mammalian Embryo
$356,586Margaret H. Baron · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · DK
MOLECULAR STUDIES OF HEMATOPOIETIC STEM CELLS
$356,530Princeton University · R37 · FY2004 · DK
Molecular Mechanism of Leukemogenesis involving AML1-ETO
$356,488Dong-Er Zhang · University Of California, San Diego · R01 · FY2024 · CA
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
$356,438Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2022 · CA
Metabolic reprogramming in breast cancer
$356,438Zhaohui Feng · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
The role of glutaminolysis as a therapeutic target in T-ALL
$356,438Daniel Herranz · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
BAK Autoactivation in Hematological Malignancies
$356,438Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2023 · CA
Mechanism of non-oncogene addiction
$356,438Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
BAK Autoactivation in Hematological Malignancies
$356,438Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2022 · CA
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
$356,438Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2023 · CA
FA pathway activities in the normal and transformed epidermis
$356,438Susanne Irmtraud Wells · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia
$356,412Michael L Cleary · Stanford University · R01 · FY2019 · CA
Molecular basis of the inhibitory effects of ATRA on osteoblast-induced MDS/AML
$356,400Stavroula Kousteni · Columbia University Health Sciences · R56 · FY2019 · AR
Clinical, Immunological and Genetic Analyses of ALPS and Related Disordrs
$356,366Vemulkonda Rao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Harnessing Alloreactivity
$356,319Fuchs Ephraim · Johns Hopkins University · P01 · FY2010 · CA
The NF-kB signaling system as a regulator of B-cell activation
$356,314Alexander Hoffmann · University Of California, San Diego · R01 · FY2012 · AI
HUMORAL REGULATION OF NORMAL AND MALIGNANT HEMATOPOIESIS
$356,297Sloan-Kettering Institute For Cancer Res · R01 · FY2000 · CA
Core 2: Animal Models
$356,287Stefan Niewiesk · Ohio State University · P01 · FY2020 · CA
Core 2: Animal Models
$356,287Stefan Niewiesk · Ohio State University · P01 · FY2021 · CA
Mechanisms of Cancer Therapy-Induced Pain
$356,268Patrick M Dougherty · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · NS
Discovering chemical tools for acute myelogenous leukemia
$356,257Jing-Ruey Joanna Yeh · Massachusetts General Hospital · R01 · FY2012 · CA
Discovery of New Targets and Pathways for T-ALL Therapy
$356,250A Thomas Look · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Prevention of quinone toxicity and mutagenicity
$356,250Baylor College Of Medicine · R01 · FY2005 · ES
Molecular Analysis of Hindbrain Development
$356,246Charles G Sagerstrom · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · NS
Washington University Institute of Clinical and Translational Sciences (TL1)
$356,236Kenneth S Polonsky · Washington University · TL1 · FY2008 · RR